Agios Pharma (AGIO) PT Raised to $53 at RBC Capital
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Price: $35.12 +2.09%
Rating Summary:
17 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
17 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay raised the price target on Agios Pharma (NASDAQ: AGIO) to $53.00 (from $44.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald on Thalassemia Opportunity
- Palo Alto Networks (PANW) PT Raised to $390 at UBS, Neutral Rating Maintained
- Moderna (MRNA) PT Raised to $89 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
